D.E. Shaw & Co
ICU icon

D.E. Shaw & Co’s SeaStar Medical ICU Stock Holding History

D.E. Shaw & Co’s Portfolio ICU Stock Details ICU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,055
Closed -$2.71M – 4966
2022
Q3 		$2.71M Hold
1,055
– – ﹤0.01% 2732
2022
Q2 		$2.68M Hold
1,055
– – ﹤0.01% 2810
2022
Q1 		$2.67M Buy
1,055
+160
+18% +$403K ﹤0.01% 3016
2021
Q4 		$2.25M Sell
895
-143
-14% -$358K ﹤0.01% 3254
2021
Q3 		$2.6M Buy
+1,038
New +$2.57M ﹤0.01% 2778

Other funds holding ICU

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's ICU Position: Q4 2022 in Review

D.E. Shaw & Co sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 1,055 shares — an estimated $2.71M sold.

D.E. Shaw & Co first reported a position in ICU in Q3 2021 and held it in 5 quarters. The position peaked at $2.71M in Q3 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

  • D.E. Shaw & Co reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,055 SeaStar Medical shares in Q4 2022, an estimated $2.71M.
  • D.E. Shaw & Co first reported a position in SeaStar Medical in Q3 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's SeaStar Medical position peaked at $2.71M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.